4/15/2021China Issues the 2021 Work Highlights of the Healthy China Initiative

4/15/2021Numerous Local Champions and MNCs Among the 19 Pharma Cos Fined by the...

4/15/2021How China Passed Up a Vaccine Opportunity and Fell Behind

4/14/2021Chinese MOF Fines 19 Pharma Companies for Inflating Drug Prices

4/14/2021Sanofi Unveils New R&D Facility in Suzhou

4/14/2021AZ's Tagrisso Approved in China as Adjuvant Treatment for Early EGFRm ...

4/14/2021StoneWise Raises $100M to Promote Use of AI in Drug Development

4/14/2021Denovo's Licenses DB102 (Enzastaurin) for Rare Genetic Pediatric Onset...

4/14/2021CAMS and PUMC Review Chinese Cancer Trends from 1990 to 2017

4/14/2021CMJ: Changing Profiles of Cancer Burden Worldwide and in China

4/14/2021Simcere's Marketing Application for First-to-copy Ibrutinib Accepted b...

4/14/2021BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...

4/14/2021Eli Lilly Licenses Greater China Rights of Alpha-synuclein Targeted Th...

4/14/2021SAMR Fines Yangtze River Pharma CNY 764M for Violations of Anti-Monop...

4/13/2021Abcam and MEDx Extend Precision Medicine Strategic Partnership

4/13/2021Pharma MNCs Step Up Alliances with Local Players in Chinese Market

4/13/2021China Approves New COVID-19 Vaccine for Clinical Trials

4/13/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

4/13/2021NMPA Revises Package Inserts of Tramadol Hydrochloride Suppository and...

4/13/2021CNIPA Invalidates Pfizer's Chinese Patent of Sutent (Sunitinib)

4/12/2021Review of R&D Spending of Listed Chinese Biopharma Firms 2018-2020

4/12/2021NMPA Accepts NDA for Ocumension's OT-401 (YUTIQ) on Real World Data

4/12/2021Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock

4/12/2021NMPA Outlines Process and Prospects of ICH in China at Latest Symposiu...

4/12/2021CDE Solicits Comments on Proposed Technical Guidelines for BE Study of...

4/12/2021PharmaDJ's China Biotech Fundraising Tracker: Feb 2021

4/12/2021FiercePharma: BeiGene Details Novartis-partnered PD-1's First Global P...

4/9/2021NMPA Issues the List of Reference Formulations for GQCE Studies (40th ...

4/9/2021Recent Executive Moves

4/8/2021Clinigen Launches Managed Access Program with BeiGene for Zanubrutinib

Page:206/790 Total number of articles:23688: [First][<<] [204] [205] [206] [207] [208] [>>] [End]